The NAD + /SIRT1/glycogen synthase kinase-3β/Nrf2 axis is an important mechanism that could protect against AKI and might be a potential therapeutic target in the treatment of AKI.890. The gene discussed is NFE2L2; the disease is acute kidney injury.